Other than its role in CML diagnosis, EVs carrying BCR/ABL were shown to be transferred to neutrophils both in vitro and in vivo, causing aberrant gene expression in the target cells that resulted in neutrophil skewing towards tumor-associated neutrophils. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.